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Background: Although the mechanism of fentanyl-induced cough is unclear, several lines of evidence suggest that
allergic mediators, such as histamine, may play a role in the production of fentanyl-induced coughs. The aim of this
study was to explore the effects of fentanyl on cough sensitivity to inhaled citric acid and on histamine release in
BALF in mice.
Methods: The cough reflex was induced by the inhalation of citric acid. Male ICR mice were exposed to a
nebulized solution of citric acid at a concentration of 0.1 M under conscious and identical conditions using a body
plethysmograph. The number of coughs produced per 3-min period of exposure to citric acid was counted.
Histamine content in BALF was analyzed by HPLC post-column derivatization and fluorescence detection.
Results: Intravenous administration of fentanyl increased the number of citric acid-induced coughs. The
fentanyl-induced enhancement of the number of citric acid-induced coughs was abolished in mice that had been
pretreated with moguisteine, a rapidly adapting receptor (RAR) antagonist or fexofenadine, a histamine H1 receptor
antagonist. Fentanyl significantly increased the concentration of histamine in BALF.
Conclusion: The results of this study suggest that fentanyl enhances the excitability of RARs to cause cough, and
enhancement of histamine release in the airways may some how be related to this change.Background
Fentanyl, a synthetic opioid, is a popular choice amongst
anesthesiologists because of its quick onset, short dur-
ation of action, ease of titrability, intense analgesia, car-
diovascular stability and low histamine release [1,2].
Although opioid agonists are known to possess antitus-
sive activity, it is well known that i.v. administration of
fentanyl paradoxically induces cough [3-7]. Fentanyl-
induced cough may be explosive at times, and may
require immediate therapeutic intervention when it
undesirably increases intracranial, intraocular or intra-
abdominal pressure [5-7]. Although the mechanism of
fentanyl-induced cough is unclear, Agarwal et al. reported
that pretreatment with salbutamol, beclomethasone or so-
dium chromoglycate reduced fentanyl-induced coughs [6].
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reproduction in any medium, provided the orand/or allergic mediators, such as histamine and leuko-
trienes, may play a role in the production of fentanyl-
induced coughs.
We previously reported that although the inhalation of
0.1 M citric acid by itself produced only a few coughs in
guinea pigs, pre-exposure to histamine concentration-
dependently increased the number of citric acid-induced
coughs [8]. This histamine-induced increase in the num-
ber of citric acid-induced coughs was dose-dependently
and significantly reduced when animals were pretreated
with fexofenadine, a histamine H1 receptor antagonist.
Based on these results, we suggested that histamine
enhances the excitability of rapidly adapting receptors in
response to tussive stimuli. It is well known that the ac-
tivation of mast cells and the systemic release of hista-
mine is a common side effect of opioids. While opioids
exert antinociceptive effects, less frequent, but perhaps
more profound, effects are the bronchoconstriction,
edema and hemodynamic instability seen in some
patients following intravenous bolus doses of opioids,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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buted to histamine release from mast cells by opioids
[9-13]. Although fentanyl has been reported to not cause
the release of histamine in plasma [14], no previous
study has examined the effects of fentanyl on histamine
in bronchoalveolar lavage fluid (BALF).
Therefore, we hypothesized that i.v. fentanyl produces
a cough reflex by increasing histamine release in BALF
and enhancing cough sensitivity to tussive stimuli. Ac-
cordingly, the aim of this study was to explore the
effects of fentanyl on cough sensitivity to inhaled citric
acid and on histamine release in BALF in mice. The
effect of fexofenadine, a histamine H1 receptor antago-
nist, on the effect of fentanyl on cough sensitivity to
inhaled citric acid was also examined.
Methods
Animals
Male ICR mice (Tokyo Animal Laboratory Inc., Tokyo,
Japan) weighing about 30 g were used. The animals had
free access to food and water in an animal room that was
maintained at 24 ± 1°C with a 12-h light–dark cycle. These
studies were carried out in accordance with the Declar-
ation of Helsinki and/or with the guide for the care and
use of laboratory animals as adopted by the committee on
the care and use of laboratory animals of Hoshi University,
which is accredited by the Ministry of Education, Culture,
Sports, Science and Technology, Japan.
Capsaicin- and citric acid-induced cough reflex
The cough reflex was induced as previously described
[8,15]. Briefly, animals were exposed to a nebulized solu-
tion of capsaicin at a concentration of 45 μM or citric
acid at a concentration of 0.1 M under conscious and
identical conditions using a body plethysmograph. The
transducer was connected to a respiratory amplifier and
polygraph to record a respiratory pattern. The trans-
ducer was also connected to respiratory analyzer and to
a personal computer, which was used for on-line breath-
by-breath measurement. Capsaicin was dissolved to a
concentration of 30 mg/ml in a 10% ethanol and 10%
Tween 80 saline solution. The stock solution of capsa-
icin was diluted with saline to a concentration of 15 μM.
Citric acid was dissolved to a concentration of 0.1 M in
a saline solution. The number of coughs produced per
3-min period of exposure to capsaicin or citric acid was
counted.
Effect of fentanyl on citric acid-induced coughs
The mice were exposed for 3 min to citric acid (0.1 M)
30 min before the i.v. injection of fentanyl (5 μg/kg) to
determine the frequency of control coughs. The mice
were also exposed for 3 min to citric acid 30 min after
the i.v. injection of fentanyl. The number of coughsproduced per 3-min period of exposure to citric acid
30 min after the i.v. injection of fentanyl was counted.
Capsaicin pretreatment
Capsaicin pretreatment was performed to evaluate the
possible roles of vagal C-fiber endings and their axonal
reflexes in eliciting coughs. A total dose of 100 mg/kg cap-
saicin was divided into four portions (20, 20, 30, and
30 mg/kg) and injected subcutaneously over 4 days under
anaesthesia with ketamine (50 mg/kg, i.m.). Terbutaline
(0.1 mg/kg, s.c.) and aminophylline (25 mg/kg, i.p.) were
given to counteract the respiratory impairment associated
with capsaicin injection. These animals were used for
experiments 2 days after the last capsaicin pretreatment.
Bronchoalveolar lavage fluid (BALF) collection
BALF was collected from the lungs of mice that had been
deeply anaesthetized with sodium pentobarbital 30 mg/kg
(i.p.). BALF was obtained by injecting 2 ml of ice-cold
physiological saline (1 ml, twice) via a tracheal cannula
30 min after i.v. injection of fentanyl (5 μg/kg). The col-
lected BALF (approximately 1 ml) was centrifuged at
1600 × g for 10 min. The supernatant fraction of the col-
lected BALF was stored at −80°C until assayed.
Histamine assay
Histamine was analyzed by HPLC post-column derivatiza-
tion and fluorescence detection. The HPLC system
consisted of an EP-300 pump (Eicom, Kyoto, Japan), an
EHA-500 post-column reagent pump system (Eicom), an
ATC-300 column oven (Eicom), a 231XL auto sampler
(Gilson, Middleton, USA) and an L-7480 fluorescence de-
tector (Hitachi, Tokyo, Japan). The mobile phase consisted
of 0.16 mol/l KH2PO4 – methanol (97:3, v/v) containing
100 mg/l sodium 1-octanesulfonate (flow rate, 0.3 ml/min).
Histamine was separated from other endogenous com-
pounds on a reversed-phase column (Eicompak SC-5ODS;
3.0 mm, i.d. × 150 mm, 5 μm, Eicom) maintained at 42°C.
The column elute was mixed with a mixture of 0.05 w/v%
o-phtalaldehyde (OPA) (flow rate, 0.06 ml/min) and
2.5 mol/l NaOH (flow rate 0.06 ml/min). Histamine was
derivatized with OPA to form a fluorescent derivative in a
reaction coil (0.25 mm, i.d. × 3 m, PEEK) maintained at
42°C. The reaction mixture was further mixed with
2 mol/l H3PO4 (flow rate, 0.13 mL/min) in a mixing
coil (0.25 mm, i.d. × 2 m, PEEK) to adjust the pH of the
final mixture. The fluorescence intensity of the final
mixture was monitored at an excitation wavelength of
340 nm and an emission wavelength of 450 nm, and
recorded by an EPC-300 data processor (Eicom).
Drugs
Fentanyl hydrochloride was purchased from Covidien




















Figure 1 Effect of fentanyl on the number of citric acid-induced
coughs in mice. The mice were exposed for 3 min to citric acid
(0.1 M) 30 min before the i.v. injection of fentanyl (5 μg/kg) to
determine the frequency of control coughs (pre-value: open
column). The mice were also exposed for 3 min to citric acid 30 min
after the i.v. injection of fentanyl. The number of coughs produced
per 3-min period of exposure to citric acid 30 min after the i.v.
injection of fentanyl (post-value: hatched column) was counted.
Each column represents the mean with S.E.M (n = 10). *P < 0.05 vs.
respective pre-value. #P < 0.05 vs. respective vehicle
(saline)-treated group.
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Figure 2 Effect of fentanyl on the number of citric acid-induced
coughs in naive (non-capsaicinized) mice and capsaicinized
mice. The mice were exposed for 3 min to citric acid (0.1 M) 30 min
before the i.v. injection of fentanyl (5 μg/kg) to determine the
frequency of control coughs (pre-value: open column). The mice
were also exposed for 3 min to citric acid 30 min after the i.v.
injection of fentanyl. The number of coughs produced per 3-min
period of exposure to citric acid 30 min after the i.v. injection of
fentanyl (post-value: hatched column) was counted. Each column
represents the mean with S.E.M (n = 10). *P < 0.05 vs. respective
pre-value. #P < 0.05 vs. respective vehicle (saline)-treated group.
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Japan) and Alpus Pharmaceutical Industries Co. (Gifu,
Japan), respectively. Fexofenadine hydrochloride was
generously supplied by Sanofi-Aventis K.K. (Tokyo,
Japan). Histamine hydrochloride was purchased from
Sigma-Aldrich Corporation (St. Louis, USA). Methanol
and sodium 1-octanesulfonate were purchased from
Nacalai Tesque Inc. (Kyoto, Japan). Ortho-phtalaldehyde
(OPA) was purchased from Wako Pure Chemical Indus-
tries, Ltd. (Osaka, Japan). Other chemicals were of the
highest purity available and used as received. Distilled
water purified with a Milli-Q reagent water system
(Millipore, Billerica, USA) was used for all aqueous solu-
tions. Fentanyl and fexofenadine were dissolved in saline
and 5% DMSO, respectively. Moguisteine was suspended
in 5% carboxylmethyl cellulose (CMC). Capsaicin was
dissolved to a concentration of 30 mg/ml in a 10% etha-
nol and 10% Tween 80 saline solution and was diluted
with saline. Moguisteine and fexofenadine was adminis-
tered s.c. 15 and 30 min before fentanyl injection,
respectively.
Statistics
Data are expressed as means ± S.E.M. The Mann–Whitney
U-test was used to assess the statistical significance of dif-
ferences in the number of coughs. Students’ T test was
used to assess the statistical significance of differences in
histamine contents in BALF. A level of probability of 0.05
or less was considered significant.
Results
Effects of fentanyl on the number of citric acid-induced
coughs
Exposure to citric acid (0.1 M) for 3 min produced about
6 coughs in mice. As shown in Figure 1, while i.v. pre-
treatment with saline did not significantly affect the
number of citric acid-induced coughs, pretreatment with
fentanyl at a dose of 5 μg/kg, i.v., significantly increased
the number of citric acid-induced coughs in mice.
Effects of fentanyl on the number of citric acid-induced
coughs in C-fiber desensitized (capsaicinized) mice
Exposure to capsaicin (45 μM) for 3 min produced 11.6 ±
1.1 coughs (n = 10) in vehicle-treated naive mice (non-
capsaicinized mice). On the other hand, the number of
coughs was significantly (P < 0.05) reduced (5.6 ± 0.7
coughs, n = 10) when capsaicin-pretreated mice (cap-
saicinized mice) were exposed to capsaicin (45 μM) for
3 min. As shown in Figure 2, i.v. pretreatment with
fentanyl at a dose of 5 μg/kg, significantly increased
the number of citric acid-induced coughs in both cap-
saicinized and non-capsaicinized mice. Pretreatment











































Figure 3 Effect of moguisteine (A) and fexofenadine (B) on the
fentanyl-induced enhancement of the number of citric acid-
induced coughs. The mice were exposed for 3 min to citric acid
(0.1 M) 30 min before the i.v. injection of fentanyl (5 μg/kg) to
determine the frequency of control coughs (pre-value: open
column). The mice were also exposed for 3 min to citric acid 30 min
after the i.v. injection of fentanyl. The number of coughs produced
per 3-min period of exposure to citric acid 30 min after the i.v.
injection of fentanyl (post-value: hatched column) was counted.
Fexofenadine (5 mg/kg) and it vehicle (5% DMSO) were
administered s.c. 30 min before the i.v. administration of fentanyl.
Moguisteine and it vehicle (5% carboxylmethyl cellulose (CMC)) were
administered s.c. 30 min before the i.v. administration of fentanyl.
Each column represents the mean with S.E.M (n = 10). *P < 0.05 vs.
respective pre-value. #P < 0.05 vs. respective vehicle-treated group.
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induced coughs.
Effects of moguisteine and fexofenadine on the fentanyl-
induced enhancement of the number of citric acid-
induced coughs
As shown in Figure 3A, the fentanyl-induced enhance-
ment of the number of citric acid-induced coughs was
abolished in mice that had been pretreated with moguis-
teine (3 mg/kg, s.c.), a rapidly adapting receptor antag-
onist. Pretreatment with fexofenadine (5 mg/kg, s.c.), a
histamine H1 receptor antagonist, also abolished the
fentanyl-induced enhancement of the number of citric
acid-induced coughs (Figure 3B).
Effect of fentanyl on the level of histamine in BALF
The concentration of histamine in BALF was signifi-
cantly increased in fentanyl (5 μg/kg, i.v.)-treated mice
compared with that in vehicle-treated mice (Figure 4).
Discussion
The stimulation of capsaicin-sensitive bronchopulmo-
nary unmyelinated C-fibers is involved in elicitation of
the cough reflex [16]. Tachykinins, like substance P,
which is contained in afferent C-fiber endings within the
airway epithelium and smooth muscle layer, are released
by the activation of afferent C-fibers. Bonham et al.
reported that substance P stimulates rapidly adapting
receptors in guinea pigs [17]. This stimulation of rapidly
adapting receptors by substance P is a potential link
between the two airway defense systems, both of which





















Figure 4 Effect of fentanyl on the level of histamine in BALF.
BALF was obtained by injecting 2 ml of ice-cold physiological saline
(1 ml, twice) via a tracheal cannula 30 min after i.v. injection of
fentanyl (5 μg/kg). Each column represents the mean with S.E.M
(n = 10). * P < 0.05 vs. vehicle (saline)-treated group.
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to the release of substance P and the subsequent stimu-
lation of rapidly adapting receptors with myelinated Aδ
fibers, has been previously proposed to explain the over-
lap of stimuli and reflex effects of both afferent systems
[18]; i.e., the activation of C-fibers by capsaicin causes
the release of substance P and the subsequent stimula-
tion of rapidly adapting receptors, which may enhance
cough reflexes. In the present study, we demonstrated
that pretreatment with fentanyl significantly increased
the number of citric acid-induced coughs in mice and
that this effect was antagonized by pretreatment with
moguisteine, a rapidly adapting receptor antagonist. Fur-
thermore, the fentanyl-induced enhancement of the
number of citric acid-induced coughs was also observed
in capsaicin-pretreated C-fiber desensitized mice. Based
on these results, it is likely that fentanyl activates mainly
rapidly adapting receptors, but not C-fibers, to enhance
citric acid-induced coughs.
In the present study, we also demonstrated that
fentanyl-induced enhancement of the number of citric
acid-induced coughs was abolished by pretreatment with
fexofenadine, a histamine H1 receptor antagonist. How-
ever, fexofenadine had no effect on the number of citric
acid-induced coughs. Furthermore, in the present study,
we also observed that fentanyl significantly increased the
histamine levels in BALF. Previously, we demons-
trated that pre-inhalation of histamine concentration-
dependently and significantly increased the number of
citric acid-induced coughs in guinea pigs, and this effect
was antagonized by pretreatment with fexofenadine [15].
These results suggest that histamine may enhance cough
receptor sensitivity through the activation of histamine
H1 receptors in the airways. We also observed that the
histamine-induced increase in the number of citric
acid-induced coughs was concentration-dependently
reduced when animals were pretreated with TNP-ATP,
P2X-type ionotropic purinergic receptor antagonist [15].
Furthermore, we reported that the ATP-induced increase
in the number of citric acid-induced coughs was
concentration-dependently reduced when animals were
pre-treated with TNP-ATP [19]. We also demonstrated
that the ATP-induced increase in the number of citric
acid-induced coughs was not abolished in C-fiber-
desensitized guinea pigs [19]. On the other hand, inhaled
ATP had no significant effect on the number of
capsaicin-induced coughs in naive animals [19]. These
results suggested that ATP activates C-fiber-independent
pathways, i.e., it directly activates rapidly adapting
receptors, to enhance citric acid-induced coughs [19].
Tamesue et al. reported that histamine induced the
release of ATP from segments of vas deferens, and this
effect was blocked by pyridamine and triprolidine, hista-
mine H1 receptor antagonists, but not by ranitidine, anH2 receptor antagonist [20]. Furthermore, histamine also
increased the release of ATP from superfused cultured
smooth muscle cells [20]. The authors suggested that ATP
might be released as an autacoid from smooth muscles in
the presence of histamine [20]. Taken together, these
results suggest that although histamine, by itself, does not
directly modulate the sensitivity of the cough reflex, it is
likely to enhance the excitability of rapidly adapting recep-
tors and/or cough receptors in response to tussive stimuli
via the modulation of ATP release in the airways. Based
on our previous and present results, it is possible that fen-
tanyl enhances the release of histamine in bronchoalveolar
tissue and this histamine first enhances the excitability of
rapidly adapting receptors through the activation of hista-
mine H1 receptors and then causes a cough reflex.
Narcotic analgesics can induce the release of histamine
both in vitro and in vivo in animals as well as in human.
However, plasma histamine levels after i.v. injection of
fentanyl are much less than those after the injection of
morphine [1,2,14]. Furthermore, incubation of human
skin mast cells with fentanyl did not induce the release
of histamine [21]. However, in the present study, i.v.
injection of fentanyl markedly increased the histamine
levels in BALF. Although further studies are needed to
determine the mechanisms that underlie these findings,
it is possible that mast cell heterogeneity may play a role
in the different effects of fentanyl on histamine release.
In conclusion, our present results suggest that fentanyl
enhances the excitability of rapidly adapting receptors to
cause cough. Furthermore, enhancement of histamine
release in the airways might some how be related to
fentanyl-induced enhancement of cough sensitivity.
However, further studies are necessary before this possi-
bility can be established with greater certainty.
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